Advisory: Alerts on dated news on GeneDx exiting two businesses withdrawn
28/10/2025 11:52
An alert on GeneDx Holdings Corp WGS.O exiting its reproductive and somatic tumor testing businesses has been withdrawn as the news is dated. The company had announced the news in statements in 2022 and 2023. STORY_NUMBER: nFWN3W90DM STORY_DATE: 28/10/2025 STORY_TIME: 10:59:03 AM GMT ((Bangalore.newsroom@thomsonreuters.com))
Recent news on GeneDx Holdings
See all newsBrief: Genedx Launches New Online Offering For Families To Improve Accessibility Of Exome Testing For Children
GeneDx Holdings Corp reports results for the quarter ended June 30 - Earnings Summary
GeneDx Q2 revenue beats analyst estimates
U.S. RESEARCH ROUNDUP-Apogee Therapeutics, GE Healthcare, Synopsys
Brief: Genedx Names Mark Gardner President To Lead Its Next Phase Of Scale And Growth